Literature DB >> 16525711

WISP-2 expression in human salivary gland tumors.

Yukinao Kouzu1, Katsuhiro Uzawa, Masaki Kato, Morihiro Higo, Yoshinori Nimura, Koji Harada, Tsutomu Numata, Naohiko Seki, Mitsunobu Sato, Hideki Tanzawa.   

Abstract

This study was designed to disclose detailed genetic mechanisms in salivary gland tumors (SGTs) for development of novel independent marker. We constructed an in-house cDNA microarray carrying 2,201 cDNA clones derived from SGT and oral squamous cell carcinoma cDNA libraries. Four cell lines that originated from the SGT-derived cell lines were analyzed using this microarray system. The genes identified by our microarray system were further analyzed at the mRNA or protein expression level in other types of human cancer cell lines and clinical samples (ten normal salivary glands [NSGs], eleven pleomorphic adenomas, ten adenoid cystic carcinomas and three adenocarcinomas). Two up-regulated genes and six down-regulated genes were identified in common when compared with the control RNA. Of the up-regulated genes, WISP-2, which plays an important role in breast carcinogenesis, was selected for further analyses. We found a higher expression of the WISP-2 gene in the SGT-derived cell lines compared with other types of human cancer cell lines. Furthermore, WISP-2 mRNA and protein expression levels in NSGs were significantly higher than those in SGTs. These results suggest that WISP-2 could be a reliable independent marker and that down-regulation or loss of the WISP-2 gene may be associated with the development of SGTs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525711

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

Review 1.  The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Authors:  Guo-Wei Zuo; Christopher D Kohls; Bai-Cheng He; Liang Chen; Wenli Zhang; Qiong Shi; Bing-Qiang Zhang; Quan Kang; Jinyong Luo; Xiaoji Luo; Eric R Wagner; Stephanie H Kim; Farbod Restegar; Rex C Haydon; Zhong-Liang Deng; Hue H Luu; Tong-Chuan He; Qing Luo
Journal:  Histol Histopathol       Date:  2010-06       Impact factor: 2.303

2.  New diagnostic markers in salivary gland tumors.

Authors:  Sven Schneider; Philipp Kloimstein; Johannes Pammer; Werner Brannath; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-04       Impact factor: 2.503

3.  The expression of Wnt-1 inducible signaling pathway protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome.

Authors:  Gelei Xiao; Zhi Tang; Xianrui Yuan; Jian Yuan; Jie Zhao; Zhiping Zhang; Zhengwen He; Jingping Liu
Journal:  Oncol Lett       Date:  2014-11-04       Impact factor: 2.967

4.  Role of the CCN protein family in cancer.

Authors:  Hyungjoo Kim; Seogho Son; Incheol Shin
Journal:  BMB Rep       Date:  2018-10       Impact factor: 4.778

Review 5.  The emerging role of WISP proteins in tumorigenesis and cancer therapy.

Authors:  Yi Liu; Yizuo Song; Miaomiao Ye; Xiaoli Hu; Z Peter Wang; Xueqiong Zhu
Journal:  J Transl Med       Date:  2019-01-16       Impact factor: 5.531

6.  Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors.

Authors:  Hui Shang; Danielle Braggio; Ya-Jung Lee; Ghadah A Al Sannaa; Chad J Creighton; Svetlana Bolshakov; Alexander J F Lazar; Dina Lev; Raphael E Pollock
Journal:  Cancer       Date:  2015-09-08       Impact factor: 6.860

Review 7.  Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).

Authors:  Jun Li; Lin Ye; Sioned Owen; Hoi Ping Weeks; Zhongtao Zhang; Wen G Jiang
Journal:  Int J Mol Med       Date:  2015-10-23       Impact factor: 4.101

8.  Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.

Authors:  Inamul Haque; Arnab Ghosh; Seth Acup; Snigdha Banerjee; Kakali Dhar; Amitabha Ray; Sandipto Sarkar; Suman Kambhampati; Sushanta K Banerjee
Journal:  BMC Cancer       Date:  2018-01-25       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.